Agonistic 4-1bb antibodies in combination with inhibitory antibodies against CTLA-4, PD-L1 or LAG-3 ACT on CD8+ T cells in the tumor microenvironment and synergize to promote regression of…

Overview of attention for article published in Journal for Immunotherapy of Cancer, November 2014

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (53rd percentile)

Mentioned by

patent: 1 patent

Readers on

mendeley: 2 Mendeley

Summary Patents

So far, Altmetric has seen 1 patent that references this research output.

PD-L1 ANTAGONIST COMBINATION TREATMENTS

Application WO-2016205277-A1

World Intellectual Property Organisation (WIPO)

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.